000 a
999 _c16295
_d16295
003 OSt
005 20220209123900.0
008 220209b xxu||||| |||| 00| 0 eng d
040 _aAIKTC-KRRC
_cAIKTC-KRRC
100 _915984
_aMessaline, Sunitha
245 _aStudy of agreement between who-uppsala monitoring c entre criteria, naranjo algorithm, and liverpool algorithm for causality assessment of adverse drug reactions
250 _aVol.13(1)
260 _aM P
_bInnovare Academic Sciences Pvt Ltd
_c2021
300 _a20-22p.
520 _aObjective: A standard causality assessment tool of an adverse drug reaction (ADR) is essential to compute the risk-benefit assessment of the medication taken by the patient and categorize its relationship likelihood. It should be reproducible and should not differ with the background and experience of the evaluator. Though there are a large number of causality assessment tools, none is unanimously accepted worldwide. So, this study was done to assess the agreement between three frequently used methods of causality assessment, the World Health Organisation-Uppsala Monitoring Centre (WHO-UMC) system, the Naranjo’s algorithm, and the Liverpool algorithm.Methods: 172 ADR forms from the pharmacovigilance unit were randomly selected for the study. Causality assessment was done using three different methods, the WHO-UMC system, Naranjo’s algorithm, and the Liver pool algorithm. Cohen’s Kappa statistics was applied to look for agreement between the causality assessment methods.Results: The agreement between the WHO-UMC criteria and Naranjo’s algorithm was the highest (136), with a Kappa value of 0.511, suggesting a moderate level of agreement. A maximum number of disagreements were noted between the WHO-UMC system and the Liverpool algorithm method (110).Conclusion: A moderate agreement exists between the WHO-UMC system and the Naranjo algorithm. There is poor agreement between the Liverpool algorithm and the other two scales. Therefore, it is recommended that both the WHO-UMC system and the Naranjo algorithm be used for causality assessment of ADRs.
650 0 _94639
_aPHARMACEUTICS
700 _915985
_aParvathy, Shobha
773 0 _dBhopal Innovare Academic Sciences Pvt Ltd
_x2656-0097
_tInternational journal of pharmacy and pharmaceutical science
856 _uhttps://innovareacademics.in/journals/index.php/ijpps/article/view/39800/24081
_yClick here
942 _2ddc
_cAR